463 related articles for article (PubMed ID: 15247455)
1. Support for the RV144 HIV vaccine trial.
Belshe R; Franchini G; Girard MP; Gotch F; Kaleebu P; Marthas ML; McChesney MB; McCullough R; Mhalu F; Salmon-Ceron D; Sekaly RP; van Rompay K; Verrier B; Wahren B; Weissenbacher M
Science; 2004 Jul; 305(5681):177-80; author reply 177-80. PubMed ID: 15247455
[No Abstract] [Full Text] [Related]
2. Policy rebuttal. HIV vaccine trial justified.
McNeil JG; Johnston MI; Birx DL; Tramont EC
Science; 2004 Feb; 303(5660):961. PubMed ID: 14963313
[No Abstract] [Full Text] [Related]
3. Support for the RV144 HIV vaccine trial.
AIDS Vaccine Advocacy Coalition
Science; 2004 Jul; 305(5681):177-80; author reply 177-80. PubMed ID: 15250069
[No Abstract] [Full Text] [Related]
4. Outstanding questions on HIV vaccine trial.
Jefferys R; Harrington M
Science; 2004 Jul; 305(5681):180; author reply 180. PubMed ID: 15247456
[No Abstract] [Full Text] [Related]
5. Public health. A sound rationale needed for phase III HIV-1 vaccine trials.
Burton DR; Desrosiers RC; Doms RW; Feinberg MB; Gallo RC; Hahn B; Hoxie JA; Hunter E; Korber B; Landay A; Lederman MM; Lieberman J; McCune JM; Moore JP; Nathanson N; Picker L; Richman D; Rinaldo C; Stevenson M; Watkins DI; Wolinsky SM; Zack JA
Science; 2004 Jan; 303(5656):316. PubMed ID: 14726576
[No Abstract] [Full Text] [Related]
6. Thailand's Prime-Boost HIV Vaccine Phase III.
Trinvuthipong C
Science; 2004 Feb; 303(5660):954-5. PubMed ID: 14963308
[No Abstract] [Full Text] [Related]
7. US and Thai Governments defend HIV/AIDS vaccine trial in Thailand.
Agnew B
Bull World Health Organ; 2004 Mar; 82(3):231. PubMed ID: 15112014
[No Abstract] [Full Text] [Related]
8. RV144: old vs. new.
Weiner DB
Hum Vaccin; 2010 Feb; 6(2):159-61. PubMed ID: 20431335
[No Abstract] [Full Text] [Related]
9. Therapeutic vaccine trails in Thailand.
Churdboonchart V
J HIV Ther; 2004 Sep; 9(3):57-9. PubMed ID: 15534562
[TBL] [Abstract][Full Text] [Related]
10. Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX B/E prime-boost HIV-1 vaccine trial in Thailand.
Karnasuta C; Paris RM; Cox JH; Nitayaphan S; Pitisuttithum P; Thongcharoen P; Brown AE; Gurunathan S; Tartaglia J; Heyward WL; McNeil JG; Birx DL; de Souza MS;
Vaccine; 2005 Mar; 23(19):2522-9. PubMed ID: 15752839
[TBL] [Abstract][Full Text] [Related]
11. HIV vaccines. Viral envelope fails to deliver?
Bolognesi DP; Matthews TJ
Nature; 1998 Feb; 391(6668):638-9. PubMed ID: 9490406
[No Abstract] [Full Text] [Related]
12. First phase I clinical trial of an HIV-1 subtype D gp140 envelope protein vaccine: immune activity induced in all study participants.
Hurwitz JL; Lockey TD; Jones B; Freiden P; Sealy R; Coleman J; Howlett N; Branum K; Slobod KS
AIDS; 2008 Jan; 22(1):149-51. PubMed ID: 18090404
[TBL] [Abstract][Full Text] [Related]
13. HIV/AIDS research. Surprising AIDS vaccine success praised and pondered.
Cohen J
Science; 2009 Oct; 326(5949):26-7. PubMed ID: 19797628
[No Abstract] [Full Text] [Related]
14. Army HIV vaccine to undergo clinical trial as rival is halted.
Check E
Nature; 2002 Mar; 416(6876):6. PubMed ID: 11882860
[No Abstract] [Full Text] [Related]
15. AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope.
Emini EA; Koff WC
Science; 2004 Jun; 304(5679):1913-4. PubMed ID: 15218131
[No Abstract] [Full Text] [Related]
16. Evaluating immune correlates in HIV type 1 vaccine efficacy trials: what RV144 may provide.
Rolland M; Gilbert P
AIDS Res Hum Retroviruses; 2012 Apr; 28(4):400-4. PubMed ID: 21902593
[TBL] [Abstract][Full Text] [Related]
17. The RV144 Thai HIV vaccine trial.
Plotkin SA
Hum Vaccin; 2010 Feb; 6(2):159. PubMed ID: 20431337
[No Abstract] [Full Text] [Related]
18. Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime/protein boost HIV-1 vaccine.
Cristillo AD; Wang S; Caskey MS; Unangst T; Hocker L; He L; Hudacik L; Whitney S; Keen T; Chou TH; Shen S; Joshi S; Kalyanaraman VS; Nair B; Markham P; Lu S; Pal R
Virology; 2006 Mar; 346(1):151-68. PubMed ID: 16325880
[TBL] [Abstract][Full Text] [Related]
19. HIV vaccine development--improving on natural immunity.
Johnston MI; Fauci AS
N Engl J Med; 2011 Sep; 365(10):873-5. PubMed ID: 21899447
[No Abstract] [Full Text] [Related]
20. Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults.
Nitayaphan S; Pitisuttithum P; Karnasuta C; Eamsila C; de Souza M; Morgan P; Polonis V; Benenson M; VanCott T; Ratto-Kim S; Kim J; Thapinta D; Garner R; Bussaratid V; Singharaj P; el-Habib R; Gurunathan S; Heyward W; Birx D; McNeil J; Brown AE;
J Infect Dis; 2004 Aug; 190(4):702-6. PubMed ID: 15272397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]